LC
AUTL

Lindbrook Capital’s Autolus Therapeutics AUTL Stock Holding History

Lindbrook Capital’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,935
Closed -$4.55K – 2792
2024
Q4 		$4.55K Hold
1,935
– – ﹤0.01% 2024
2024
Q3 		$7.02K Hold
1,935
– – ﹤0.01% 1851
2024
Q2 		$6.73K Hold
1,935
– – ﹤0.01% 1851
2024
Q1 		$12.3K Hold
1,935
– – ﹤0.01% 1458
2023
Q4 		$12.5K Hold
1,935
– – ﹤0.01% 1425
2023
Q3 		$4.51K Hold
1,935
– – ﹤0.01% 1814
2023
Q2 		$4.61K Hold
1,935
– – ﹤0.01% 1845
2023
Q1 		$3.56K Hold
1,935
– – ﹤0.01% 2000
2022
Q4 		$3.68K Buy
+1,935
New +$4.89K ﹤0.01% 1963
2022
Q3 		– Sell
-177
Closed -$1K – 2617
2022
Q2 		$1K Sell
177
-216
-55% -$657 ﹤0.01% 2144
2022
Q1 		$2K Sell
393
-1,209
-75% -$5.08K ﹤0.01% 1937
2021
Q4 		$8K Sell
1,602
-2,314
-59% -$13.9K ﹤0.01% 1340
2021
Q3 		$26K Sell
3,916
-3,966
-50% -$25.1K 0.01% 648
2021
Q2 		$52K Buy
7,882
+4,882
+163% +$30.3K 0.01% 463
2021
Q1 		$17K Buy
3,000
+2,393
+394% +$17.7K ﹤0.01% 796
2020
Q4 		$5K Buy
607
+112
+23% +$1.19K ﹤0.01% 1162
2020
Q3 		$6K Hold
495
– – ﹤0.01% 1003
2020
Q2 		$8K Sell
495
-121
-20% -$1.34K ﹤0.01% 890
2020
Q1 		$4K Buy
+616
New +$5.69K ﹤0.01% 1060

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lindbrook Capital's AUTL Position: Q1 2025 in Review

Lindbrook Capital sold out of Autolus Therapeutics (AUTL) in Q1 2025, closing a stake of 1,935 shares — an estimated $4.55K sold.

Lindbrook Capital first reported a position in AUTL in Q1 2020 and held it in 19 quarters. The position peaked at $52K in Q2 2021. 95 funds tracked by Wall St. Rank hold AUTL as of Q1 2025.

  • Lindbrook Capital reported no remaining Autolus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 1,935 Autolus Therapeutics shares in Q1 2025, an estimated $4.55K.
  • Lindbrook Capital first reported a position in Autolus Therapeutics in Q1 2020 and held it in 19 quarters.
  • Lindbrook Capital's Autolus Therapeutics position peaked at $52K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.